Current Suspected Overdose Deaths in Delaware for 2024: Get Help Now!
Find school water testing results and additional resources
Attention Medicaid Participants: Eligibility Renewals Restarted April 1, 2023
Molly Magarik, Secretary
Jill Fredel, Director of Communications
302-255-9047, Cell 302-357-7498
Email: Jill.Fredel@delaware.gov
DPH Media Contact:
Mary Fenimore
Email: DPHMedia@Delaware.gov
Date: June 18, 2022
DHSS-6-2022
DOVER, DE (June 17, 2022) - The Delaware Division of Public Health (DPH) reports an overall decrease in COVID-19 cases and hospitalization since the previous monthly COVID-19 update released on May 21, 2022. While COVID-19 cases, hospitalizations, and deaths are experiencing a decreasing trend, DPH encourages Delawareans to rely on trusted prevention actions to stay one step ahead of COVID-19 during this event-filled weekend that includes Father Day, Juneteenth, and ongoing Pride celebrations. Delawareans can stay safe by:
Vaccine for Infants and Children On June 15, the FDA's medical advisory committee VRBPAC, authorized Moderna's vaccine for children ages 6 months through 5 years old and Pfizer's vaccine for children ages 6 months through 4 years old. The FDA Director Peter Marks signed off on the committee's authorization on Friday, June 17. The CDC's advisory committee met earlier today on June 17th to discuss the vaccines. The committee is expected to vote on their use on Saturday, June 18th. A formal sign-off is still required from the Centers for Disease Control and Prevention (CDC) director before vaccine administration can begin.
The first shipments of vaccine for children under 5 years old will arrive in Delaware on June 20th, and the earliest that vaccine administrations, pending the CDC's vote, are expected to begin is June 21st (though this may vary by site). Not all providers ordered vaccine for this first wave. The Division of Public Health has placed information about these pediatric vaccines on de.gov/youthvaccine. New locations will be added regularly.
The Moderna COVID-19 Vaccine is administered as a primary series of two doses, one month apart, to individuals 6 months through 5 years of age. Effectiveness varies by age. The most commonly reported side effects across all age subgroups included pain, redness and swelling at the injection site, fever and underarm swelling/tenderness at the injection site.
The Pfizer-BioNTech COVID-19 Vaccine is administered as a primary series of three doses in which the initial two doses are administered three weeks apart followed by a third dose administered at least eight weeks after the second dose in individuals 6 months through 4 years of age. The most common side effects included irritability, decreased appetite, fever, headache, chills and pain, tenderness, redness and swelling at the injection site.
COVID-19 Cases and Hospitalizations:
COVID-19 Vaccinations:
All qualifying Delawareans should get vaccinated. For a location near you, visit de.gov/getmyvaccine.. Delaware's latest COVID-19 vaccination statistics can be found under the Vaccine Tracker dashboard at de.gov/healtycommunity
COVID-19 Case Vaccination Status Report:
The following reports capture a weekly breakdown of non-boosted cases, deaths, and hospitalizations for the time frame of June 06 - June 12, 2022.
|
Weekly Overview (06/06/22 - 06/12/22) |
# of Non-boosted Cases |
|---|---|
| Total Non-boosted | 1573 |
| Total Cases | 2258 |
| Percent of Non-boosted Cases | 69% |
| Non-boosted Hospitalized cases | # of Cases |
|---|---|
| Total Non-boosted Hospitalized Cases | 96 |
| Total Hospitalized Cases | 147 |
| Percent of Non-boosted Cases | 65% |
| Non-boosted Deaths | # of Cases |
|---|---|
| Total Non-boosted Deaths | 0 |
| Total COVID-19 Deaths | 1 |
| Percent of Non-boosted Deaths | 0% |
Long-term Care Statistics:
As of Friday, June 17, 2022, there have been a total of 4,060 positive COVID-19 cases involving long-term care residents, and 964 residents of Delaware long-term care facilities have died from complications related to COVID-19.
Resources:
Individuals with general questions about COVID-19 should call Delaware 2-1-1, individuals who are deaf or hard of hearing can text their ZIP code to 898-211, or email delaware211@uwde.org. Hours of operation are:
Monday - Friday: 8:00 a.m. to 9:00 p.m.
Saturday: 9:00 a.m. to 5:00 p.m.
Medically related questions regarding testing, symptoms, and health-related guidance can be submitted by email at DPHCall@delaware.gov.
For the latest information on the flu in Delaware, visit flu.delaware.gov
Delawareans 18 or older are encouraged to download COVID Alert DE, Delaware's free exposure notification app to help protect your neighbors while ensuring your privacy. Download on the App Store or Google Play.
DPH will continue to update the public as more information becomes available. For the latest on Delaware's response, go to de.gov/coronavirus.
Delaware Health and Social Services is committed to improving the quality of the lives of Delaware's citizens by promoting health and well-being, fostering self-sufficiency, and protecting vulnerable populations.
About the Department
Secretary's Letter
Secretary Bio
Newsroom
State Jobs
Calendar
Delaware Health Care Commission
DHSS Administration Contact
Federal COVID Funding Dashboard
Delaware's Governor
State Agencies
Elected Officials
General Assembly
Delaware Courts
State Employees
Cities & Towns
Delaware State Code
State Regulations
Business First Steps
Phone Directory
Locations Directory
Public Meetings
Voting & Elections
Transparency
Delaware Marketplace
Tax Center
Personal Income Tax
Privacy Policy
Weather & Travel
Contact Us
Corporations
Franchise Tax
Gross Receipts Tax
Withholding Tax
Delaware Topics
Help Center
Mobile Apps
E-mail / Text Alerts
Social Media
Built by the Government Information Center
©MMXVIII Delaware.gov
